IMIPENEM/CILASTATINE HIKMA 500 mg/500 mg, powder for solution for infusion 10 bottles of 20 ml
Active ingredients: Cilastatin, Cilastatin sodium, IMIPÉNEM ANHYDRE, Imipenem hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMIPENEM/CILASTATINE HIKMA 500 mg/500 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacons en verre de 20 mL
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Apr 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63848121CIP75506498CIP133400955064985Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMIPÉNEM MONOHYDRATÉpoudre | 530 mg · un flacon | SA |
| CILASTATINE SODIQUEpoudre | 530 mg · un flacon | SA |
| IMIPÉNEM ANHYDREpoudre | 500 mg · un flacon | FT |
| CILASTATINEpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.